These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37170791)

  • 61. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy.
    Hu N; Niu J; Liu M
    Neurol Sci; 2022 Oct; 43(10):5885-5898. PubMed ID: 35737187
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP).
    Querol L; Crabtree M; Herepath M; Priedane E; Viejo Viejo I; Agush S; Sommerer P
    J Neurol; 2021 Oct; 268(10):3706-3716. PubMed ID: 32583051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with diabetes mellitus - treatment with intravenous immunoglobulins: A systematic review.
    Andrusiów S; Pawlak Z; Stańczykiewicz B; Bogunia-Kubik K; Koszewicz M
    Biomed Pharmacother; 2023 Aug; 164():114974. PubMed ID: 37290187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)--a review].
    Mezaki T; Kaji R
    No To Shinkei; 2000 Dec; 52(12):1063-9. PubMed ID: 11193538
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study.
    Bus SRM; Broers MC; Lucke IM; Bunschoten C; van Lieverloo GGA; Adrichem ME; van Veen R; Wieske L; Lingsma HF; Goedee HS; van der Pol WL; van Schaik IN; Van Doorn PA; Jacobs BC; Eftimov F;
    J Neurol; 2022 Feb; 269(2):945-955. PubMed ID: 34173873
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of CIDP.
    Fehmi J; Bellanti R; Misbah SA; Bhattacharjee A; Rinaldi S
    Pract Neurol; 2023 Feb; 23(1):46-53. PubMed ID: 36109154
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Topics of chronic inflammatory demyelinating polyradiculoneuropathy--diagnosis and treatment situation in Japan].
    Iijima M
    Rinsho Byori; 2013 May; 61(5):407-13. PubMed ID: 23947179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
    Fukushima K; Ikeda SI
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():414-8. PubMed ID: 26480734
    [No Abstract]   [Full Text] [Related]  

  • 76. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Hughes R
    J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Chronic Inflammatory Demyelinating Polyneuropathy].
    Balke M; Wunderlich G; Brunn A; Fink GR; Lehmann HC
    Fortschr Neurol Psychiatr; 2016 Dec; 84(12):756-769. PubMed ID: 27951607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
    Dalakas MC; Latov N; Kuitwaard K
    Expert Rev Neurother; 2022; 22(11-12):953-962. PubMed ID: 36645654
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.
    Broers MC; Bunschoten C; Nieboer D; Lingsma HF; Jacobs BC
    Neuroepidemiology; 2019; 52(3-4):161-172. PubMed ID: 30669140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.